ALPINE IMMUNE SCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q1 2024.
  • Alpine Immune Sciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $3.99M, a 56.3% increase year-over-year.
  • Alpine Immune Sciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $12.1M, a 21.8% increase year-over-year.
  • Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 10.2% increase from 2022.
  • Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.65M, a 54.6% increase from 2021.
  • Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.24M, a 50.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $12.1M $3.99M +$1.44M +56.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.6M $2.8M +$334K +13.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $10.3M $2.65M +$99K +3.88% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $10.2M $2.62M +$286K +12.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $9.91M $2.55M +$263K +11.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $9.65M $2.47M +$1.01M +69.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $8.64M $2.56M +$917K +56% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $7.72M $2.34M +$790K +51.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $6.93M $2.29M +$692K +43.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $6.24M $1.46M +$511K +53.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-20
Q3 2021 $5.73M $1.64M +$665K +68.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $5.06M $1.55M +$313K +25.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $4.75M $1.6M +$611K +62% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $4.14M $949K +$169K +21.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $3.97M $973K +$148K +17.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.82M $1.23M +$550K +80.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $3.27M $986K +$232K +30.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $3.04M $780K +$49K +6.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $2.99M $825K +$281K +51.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $2.71M $682K +$159K +30.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $2.55M $754K +$243K +47.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $2.31M $731K +$422K +137% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 $1.89M $544K +$315K +138% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.57M $523K +$275K +111% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $1.3M $511K +$459K +883% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $838K $309K +$1.65M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 -$813K $229K +$217K +1808% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$1.03M $248K -$452K -64.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$578K $52K -$655K -92.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $77K -$1.34M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $12K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $700K Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-21
Q1 2016 $707K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.